Nikita Kolhatkar

Nikita Kolhatkar is a professional working at Gilead Sciences in the San Francisco Bay Area. She holds the position of Clinical Biomarker Lead in the Biomarker Sciences department.1 Kolhatkar has a strong educational background, having earned a PhD in Immunology from the University of Washington and a Bachelor of Arts in Biology from Mount Holyoke College.

Professional Experience

At Gilead Sciences, Kolhatkar is involved in research work related to biomarkers and immunology. Her contributions to the field are evident from her research publications, which have garnered 116 citations.2 One of her notable works includes research on TLR8 agonist selgantolimod and its effects on Kupffer cell differentiation and HBV impairment.2

Networking and Influence

Kolhatkar maintains an active professional network, with over 500 connections on LinkedIn.1 This extensive network suggests she is well-connected within her industry and potentially influential in her field of expertise.

Research Interests

Based on her published works, Kolhatkar's research interests appear to be focused on immunology, particularly in the context of drug development and infectious diseases. Her work at Gilead Sciences likely involves the development and application of biomarkers in clinical research and drug development processes.

Nikita Kolhatkar's combination of advanced education in immunology and her role at a major pharmaceutical company positions her as a significant contributor to the field of biomarker sciences and drug development.